Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Remenyi
The Role of Measurable Residual Disease (MRD) at Time of Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Lymphoblastic Leukemia Transplanted After Myeloablative Conditioning. A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Thiotepa-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia-A Survey From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
American Journal of Hematology
Hematology
Non-Myeloablative Conditioning With Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia
Haematologica
Hematology
Impact of Graft-Versus-Host Disease After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Measurable Residual Disease, Conditioning Regimen Intensity and Age Predict Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Remission: A Registry Analysis of 2292 Patients by the Acute Leukemia Working Party Eu
American Journal of Hematology
Hematology
Outcomes of Allogeneic Hematopoietic Cell Transplantation for AML With Complex Karyotypes: A Retrospective Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and MD Anderson Cancer Center
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- A Report From the Acute Leukemia Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
